Authors: Andrea Madeo, Silvana De Bonis, Anna Lucia Cavaliere, Giovanni Bisignani
Heart failure (HF) with reduced ejection fraction remains a significant global health challenge despite advances in medical therapy. Cardiac contractility modulation (CCM) is a promising treatment for symptomatic HF patients who are ineligible for cardiac resynchronization therapy (CRT). Non-invasive methods to assess the acute hemodynamic effects of CCM are critical to optimize care and guide treatment. This study aimed to evaluate the acute impact of CCM on stroke volume (SV) and total peripheral resistance index (TPRI) using the non-invasive bioimpedance-based system (NICaS®).
Conclusions: NICaS® provided a reliable, non-invasive tool for monitoring these acute hemodynamic changes, supporting its use in clinical practice.
For the full article click here
